Immunis wins corporate livewire's 2023 “innovation and excellence award”

Irvine, calif.--(business wire)-- #clinicaltrials--immunis, inc., a private biotech creating novel cellular secretome therapies for age and disease-related immune decline, was bestowed corporate livewire's prestigious “innovation and excellence award.” corporate livewire is highly regarded in the business world, acknowledging the stellar performance of leading companies with technological innovation. immunis' cutting-edge research and transformative secretome technologies have undoubtedly set the company apart a.
LVWR Ratings Summary
LVWR Quant Ranking